Andrew Arno
CIK 1472122 · last filed 2026-03-30
Andrew Arno is a corporate insider who has filed 59 SEC Form 4 insider transactions across 6 companies since 2015. The most recent filing, for VTAK, was dated Mar 30, 2026. Across all open-market trades the lifetime net is +$618.5K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $372.8K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$372.8K
6
59
$618.5K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| VTAK | Director | — | $1.05 | — | $0 | 3 | 2026-03-30 |
| SMSI | Director | 89,882 | $2.88 | $258.4K | $99.5K | 19 | 2026-03-10 |
| XXII | Director | 17,481 | $6.54 | $114.4K | $17.5K | 3 | 2025-11-14 |
| Insight Molecular Diagnostics Inc. (OCX) Delisted | Director | 144,358 | $3.20 | $461.9K | $480.0K | 20 | 2025-07-03 |
| Asterias Biotherapeutics, Inc. (AST) Delisted | Director | 5,000 | — | — | $21.6K | 4 | 2018-06-25 |
| Asterias Biotherapeutics, Inc. (AST.WS) Delisted | Director | — | — | — | $0 | 1 | 2017-04-03 |
Recent Filings
59 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-03-30 | VTAK | Grant (A) | — | $0 | EDGAR |
| 2026-03-10 | SMSI | Grant (A) | +12,500 | $0 | EDGAR |
| 2025-11-14 | XXII | Grant (A) | +17,295 | $0 | EDGAR |
| 2025-10-29 | SMSI | Grant (A) | +7,993 | $0 | EDGAR |
| 2025-08-14 | VTAK | Grant (A) | — | $0 | EDGAR |
| 2025-07-03 | Insight Molecular Diagnostics Inc. (OCX) Delisted | Grant (A) | +55,000 | $0 | EDGAR |
| 2025-03-12 | XXII | Grant (A) | +4,237 | $0 | EDGAR |
| 2025-01-31 | VTAK | Grant (A) | — | $0 | EDGAR |
| 2025-01-27 | SMSI | Grant (A) | +25,000 | $0 | EDGAR |
| 2024-12-26 | Insight Molecular Diagnostics Inc. (OCX) Delisted | Buy (P) | +12,500 | $26.4K | EDGAR |